2005
DOI: 10.1016/j.jmmm.2005.01.083
|View full text |Cite
|
Sign up to set email alerts
|

Targeted drug delivery to magnetic implants for therapeutic applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
95
0
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(97 citation statements)
references
References 12 publications
1
95
0
1
Order By: Relevance
“…Thus, the average projection of m the moment in the direction of B total can be calculated from the Langevin function [6,8,22,23,24]…”
Section: Accepted Manuscriptmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the average projection of m the moment in the direction of B total can be calculated from the Langevin function [6,8,22,23,24]…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Specifically it can be difficult using external magnets only to target areas deep within the body, without targeting the surface more strongly [6]. To overcome this problem several authors [7,8,9,10,11,12,13,14,15,16] have proposed implanting ferromagnetic materials such as wires, seeds and stents within the body. Of the various IA-MTD implants suggested by Ebner, Ritter and coworkers [9,10,11,12,13,14,15,16], we consider a magnetizable stent as the implant, with MDCPs containing magnetic single domain nanoparticles.…”
Section: Introductionmentioning
confidence: 99%
“…These advanced materials are used in key applications such as drug/gene delivery, magnetic drug targeting, thermotherapies, stem cell targeting, and in diagnostic imaging (as contrast agents) [2][3][4][5][6]. The size and surface chemistry of MPs can be tailored for molecules with which they are 'functionalized', enabling the construction of multimodal particles that can mediate combinations of cellular applications, whilst retaining nanoscale dimensions [7].…”
Section: Introductionmentioning
confidence: 99%
“…Experimental results have demonstrated that capturing superparamagnetic beads of both micrometer and submicrometer diameter at reasonably high concentrations is possible in flow conditions consistent with the dimensions and flow velocity occurring in the coronary artery in the human body. The same experiments performed with non-magnetic mesh resulted in no significant capture, indicating that the implant is responsible for providing the necessary magnetic field gradients and forces to capture the injected beads (Yellen et al, 2005).…”
Section: Magnetic Targetingmentioning
confidence: 83%